Hepatitis B vaccine and risk of autoimmune thyroid disease: A Vaccine Safety Datalink study

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 7, 2007, Pages 736-745

  Yu, Onchee ^a   Bohlke, Kari ^a   Hanson, Christi A ^a   Delaney, Kristin ^a   Rees, Thomas G ^a   Zavitkovsky, Ann ^a   Ray, Paula ^b   Mullooly, John ^b   Black, Steven B ^b   Benson, Patti ^a   Thompson, William W ^c   Davis, Robert L ^c,d   Jackson, Lisa A ^a,d  

^a CENTER FOR HEALTH STUDIES   (United States)

^b KAISER PERMANENTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmune thyroid disease; Graves' disease; Hashimoto's thyroiditis; Hepatitis B vaccine; Vaccine Safety Datalink

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VACCINATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS;

EID: 34547534648     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1354     Document Type: Article

References (12)

1. Chen RT, Pless R, DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001; 16: 309-318.
2. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920.
3. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001; 14: 227-250.
4. Sturkenboom MC, Heinzlef O, Roullet E, Rozenberg S, Begaud B, Fautrel B. Vaccination against Hepatitis B and Graves' Disease. Pharmacoepidemiol Drug Safe 2000; 9: S70.
5. DeStefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Safe 2001; 10: 403-406.
6. Burch HB, Bernet VJ, Plotkin FR et al. Graves Disease in a US Army Special Forces Group. JAMA 2002; 288: 2975-2976.
7. Hernan MA, Jick SS, Olek MI, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004; 63: 838-842.
8. World Health Organization Global Advisory Committee on Vaccine Safety: response to the paper by MA Hernan and others in Neurology 14th September 2004 issue entitled Recombinant hepatitis B vaccine and the risk of multiple sclerosis. September 2004. Available from URL: http://www.who.int/vaccine_safety/topics/hepatitisb/multiple_sclerosis/ sep_04/en/print.html
9. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243.
10. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003; 348: 2646-2655.
11. Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol (Oxf) 2004; 60: 397-409.
12. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001; 345: 340-350.